Enzo-logo-750-500.jpg
Enzo Biochem Reports First Quarter Fiscal 2021 Financial Results and Provides Business Update
09. Dezember 2020 16:01 ET | Enzo Biochem, Inc.
Company reports $28.7 million in revenue, exceeding revenue guidance by $1.7 million and representing a 47% increase over sequential quarter and continued recovery and opportunity from impact of...
Enzo-logo-750-500.jpg
Enzo Biochem to Report First Quarter 2021 Financial Results on Wednesday, December 9
02. Dezember 2020 08:00 ET | Enzo Biochem, Inc.
Conference Call and Webcast Scheduled for December 9, 2020, 4:30 pm ET NEW YORK, NY, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics...
Enzo-logo-750-500.jpg
ENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORS
25. November 2020 08:00 ET | Enzo Biochem, Inc.
NEW YORK, NY, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “The Company”), a leading biosciences and diagnostics company, announced today that Ian B. Walters, MD, has...
Enzo-logo-750-500.jpg
ENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD, TO ITS BOARD OF DIRECTORS
18. November 2020 08:05 ET | Enzo Biochem, Inc.
NEW YORK, NY, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “the Company”), a leading biosciences and diagnostics company, announced today that Mary Tagliaferri, MD, has...
Enzo-logo-750-500.jpg
ENZO PROVIDES CORPORATE BUSINESS UPDATE
17. November 2020 08:00 ET | Enzo Biochem, Inc.
NEW YORK, NY, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “The Company”), a leading biosciences and diagnostics company, announced today that the company estimates...
Enzo-logo-750-500.jpg
ENZO LAUNCHES PORTABLE MICROPLATE READER FOR USE WITH ITS ELISA AND ASSAY KITS TO SIMPLIFY LABORATORY WORKFLOW
05. November 2020 08:00 ET | Enzo Biochem, Inc.
- Powerful and precise compact instrument enables Enzo to offer a  complete solution to advance drug discovery - Microplate reader can be retrofitted for point-of-care clinical testing at...
Enzo-logo-750-500.jpg
ENZO BIOCHEM LAUNCHES GOTESTMENOW™ ONLINE PLATFORM FOR CONSUMERS TO DIRECTLY ORDER COVID-19 LABORATORY TESTS
27. Oktober 2020 08:00 ET | Enzo Biochem, Inc.
Direct-to-Consumer service will initially offer access to COVID-19 molecular and antibody testing and will expand to include other testing in the future Enzo’s first-ever DTC testing...
Enzo-logo-750-500.jpg
Enzo Biochem Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
13. Oktober 2020 16:01 ET | Enzo Biochem, Inc.
Company reports $19.5 million in revenue and EPS of ($0.07) in the fourth quarter with significant margin expansion supported by rapid response to COVID-19 market opportunitiesQ1 21 first two months’...
Enzo-logo-750-500.jpg
Enzo Biochem to Report Fourth Quarter and Fiscal Year 2020 Financial Results on Tuesday, October 13
06. Oktober 2020 15:42 ET | Enzo Biochem, Inc.
Conference Call and Webcast Scheduled for October 13, 2020, 4:30 pm ET NEW YORK, NY, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics...
Enzo-logo-750-500.jpg
ENZO BIOCHEM DOUBLES CAPACITY IN RESPONSE TO INCREASING DEMAND FOR COVID-19 TESTING
08. September 2020 08:00 ET | Enzo Biochem, Inc.
NEW YORK, NY, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it has expanded reagent and supply manufacturing...